Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
trend decrease » teer decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
trend decrease » teer decrease (Expand Search)
-
3361
-
3362
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
3363
-
3364
-
3365
-
3366
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
3367
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
3368
-
3369
-
3370
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
3371
-
3372
-
3373
-
3374
-
3375
-
3376
-
3377
-
3378
-
3379
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
3380